322
Views
8
CrossRef citations to date
0
Altmetric
Articles

Vitamin D supplementation alters the expression of genes associated with hypertension and did not induce DNA damage in rats

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Afman, L., and M. Muller. 2006. Nutrigenomics: From molecular nutrition to prevention of disease. J Am Diet Assoc. 106:569–76. doi:10.1016/j.jada.2006.01.001.
  • Almeida, M. R., E. de Oliveira Lima, V. J. Da Silva, M. G. Campos, L. M. Antunes, A. K. Salman, and F. L. Dias. 2008. Genotoxic studies in hypertensive and normotensive rats treated with amiodarone. Mutat. Res. 657:155–59. doi:10.1016/j.mrgentox.2008.09.005.
  • Babicki, S., D. Arndt, A. Marcu, Y. Liang, J. R. Grant, A. Maciejewski, and D. S. Wishart. 2016. Heatmapper: Web-enabled heat mapping for all. Nucl. Acids Res. 44:147–53. doi:10.1093/nar/gkw419.
  • Banakar, M. C., S. K. Paramasivan, M. B. Chattopadhyay, S. Datta, P. Chakraborty, M. Chatterjee, K. Kannan, and E. Thygarajan. 2004. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World J. Gastroenterol. 10:1268–75.
  • Barton, M., and M. Yanagisawa. 2008. Endothelin: 20 years from discovery to therapy. Can. J. Physiol. Pharmacol. 86:485–98. doi:10.1139/Y08-059.
  • Bers, D. M. 2002. Cardiac excitation-contraction coupling. Nature 415:198–205. doi:10.1038/415198a.
  • Bolbrinker, J., S. Seeberg, M. Schostak, C. Kempkensteffen, H. Baelde, E. de Heer, and R. Kreutz. 2012. Drug Metab. Dispos. 40:639–41. doi:10.1124/dmd.111.042648.
  • Breysse, C., P. Guillot, and G. Berrut. 2015. [Study of vitamin D supplementation in people over 65 years in primary care]. Geriatr. Psychol. Neuropsychiatr. Vieil. 13:123–32. doi:10.1684/pnv.2015.0530.
  • Burrell, L. M., S. B. Harrap, E. Velkoska, and S. K. Patel. 2013. The ACE2 gene: Its potential as a functional candidate for cardiovascular disease. Clin. Sci. 124:65–76. doi:10.1042/CS20120269.
  • Castro, L. C. 2011. The vitamin D endocrine system. Arq. Bras Endocrinol. Metabol. 55:566–75.
  • Chappell, M. C. 2015. Biochemical evaluation of the renin-angiotensin system: The good, bad and absolute? Am. J. Physiol. Hearth Circ. Physiol. 310:H137–H152. doi:10.1152/ajpheart.00618.2015.
  • Chen, X., W. Li, H. Yoshida, S. Tsuchida, H. Nishimura, F. Takemoto, S. Okubo, A. Fogo, T. Matsusaka, and I. Ichikawa. 1997. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am. J. Physiol. 272:F299–F304. doi:10.1152/ajprenal.1997.272.3.F299.
  • Collett, J. A., A. K. Hart, E. Patterson, J. Kretzer, and J. L. Osborn. 2013. Renal angiotensin II type 1 receptor expression and associated hypertension in rats with minimal SHR nuclear genome. Physiol Rep. 1:e00104. doi:10.1002/phy2.104.
  • Contreras, F., C. Fouillioux, A. Bolivar, N. Simonovis, R. Hernandez-Hernandez, M. J. Armas-Hernandez, and M. Velasco. 2002. Dopamine, hypertension and obesity. J. Hum. Hypertens. 16 (Suppl 1):S13–S17. doi:10.1038/sj.jhh.1001334.
  • Cortes, R., M. Rivera, E. Rosello-Lleti, L. Martinez-Dolz, L. Almenar, I. Azorin, F. Lago, J. R. Gonzalez-Juanatey, and M. Portoles. 2012. Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology. PLoS One 7:e30915. doi:10.1371/journal.pone.0030915.
  • Cushman, D. W., and M. A. Ondetti. 1980. Inhibitors of angiotensin-converting enzyme for treatment of hypertension. Biochem. Pharmacol. 29:1871–77.
  • Danilczyk, U., and J. M. Penninger. 2006. Angiotensin-converting enzyme II in the heart and the kidney. Circ. Res. 98:463–71. doi:10.1161/01.RES.0000205761.22353.5f.
  • Doggrell, S. A., and L. Brown. 1998. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc. Res. 39:89–105.
  • Donoghue, M., F. Hsieh, E. Baronas, K. Godbout, M. Gosselin, N. Stagliano, M. Donovan, B. Woolf, K. Robison, R. Jeyaseelan, et al. 2000. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 87 (5):E1–E9.
  • Draper, H. H., and M. Hadley. 1990. Malondialdehyde determination as index of lipid peroxidation. Meth. Enzymol. 186:421–31.
  • Fagundes, G. E., A. P. Damiani, T. P. Macan, P. Rohr, A. C. Felipe, F. R. Rocha, L. T. Tomasi, C. Lourenço, M. T. Rodrigues, L. B. Ceretta, et al. 2015. Influence of vitamin D treatment on the genomic instability of patients with type 2 diabetes mellitus. Frontiers in Genetics Conference Abstract: ICAW 2015 - 11th International Comet Assay Workshop. doi:10.3389/conf.fgene.2015.01.00016.
  • Griffin, F. C., C. A. Gadegbeku, and M. R. Sowers. 2011. Vitamin D and subsequent systolic hypertension among women. Am. J. Hypertens. 24:316–21. doi:10.1038/ajh.2010.226.
  • Haloui, M., J. Tremblay, O. Seda, S. V. Koltsova, G. V. Maksimov, S. N. Orlov, and P. Hamet. 2013. Increased renal epithelial channel expression and activity correlate with elevation of blood pressure in spontaneously hypertensive rats. Hypertension 62:731–37. doi:10.1161/HYPERTENSIONAHA.113.01295.
  • Hartree, E. F. 1972. Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 48:422–27.
  • Holick, M. F. 2007. Vitamin D deficiency. N. Engl. J. Med. 357:266–81. doi:10.1056/NEJMra070553.
  • Horn, P. T., and M. B. Murphy. 1991. Dopamine receptor agonists in cardiovascular medicine. Trends Cardiovasc. Med. 1:103–07. doi:10.1016/1050-1738(91)90002-V.
  • Hossein-Nezhad, A., and M. F. Holick. 2012. Optimize dietary intake of vitamin D: An epigenetic perspective. Curr. Opin. Clin. Nutr. Metab. Care. 15:567–79. doi:10.1097/MCO.0b013e3283594978.
  • Hossein-Nezhad, A., and M. F. Holick. 2013. Vitamin D for health: A global perspective. Mayo Clin. Proc. 88:720–55. doi:10.1016/j.mayocp.2013.05.011.
  • Hupf, H., D. Grimm, G. A. Riegger, and H. Schunkert. 1999. Evidence for a vasopressin system in the rat heart. Circ. Res. 84:365–70.
  • Imig, J. D., X. Zhao, J. H. Capdevila, C. Morisseau, and B. D. Hammock. 2002. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39:690–94.
  • Jones, G. 2008. Pharmacokinetics of vitamin D toxicity. Am. J. Clin. Nutr. 88:582S–586S. doi:10.1093/ajcn/88.2.582S.
  • Kennel, K. A., M. T. Drake, and D. L. Hurley. 2010. Vitamin D deficiency in adults: When to test and how to treat. Mayo Clin. Proc. 85:752–57 quiz 757-758. doi:10.4065/mcp.2010.0138.
  • Kerr, S., M. J. Brosnan, M. McIntyre, J. L. Reid, A. F. Dominiczak, and C. A. Hamilton. 1999. Superoxide anion production is increased in a model of genetic hypertension: Role of the endothelium. Hypertension 33:1353–58.
  • Kim, S. M., P. L. Lutsey, and E. D. Michos. 2017. Vitamin D and cardiovascular disease: Can novel measures of vitamin D status improve risk prediction and address the vitamin D racial paradox? Curr. Cardiovasc. Risk Rep. 11:1–15. doi:10.1007/s12170-017-0528-7.
  • Lavie, C. J., J. H. Lee, and R. V. Milani. 2011. Vitamin D and cardiovascular disease will it live up to its hype? J. Am. Coll. Cardiol. 58:1547–56. doi:10.1016/j.jacc.2011.07.008.
  • Lee, H. A., H. M. Cho, D. Y. Lee, K. C. Kim, H. S. Han, and I. K. Kim. 2012. Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension 59:621–26. doi:10.1161/HYPERTENSIONAHA.111.182428.
  • Lee, J. H., J. H. O’Keefe, D. Bell, D. D. Hensrud, and M. F. Holick. 2008. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 52:1949–56. doi:10.1016/j.jacc.2008.08.050.
  • Levine, M. A. 2003. Normal mineral homeostasis. Interplay of parathyroid hormone and vitamin D. Endocr. Dev. 6:14–33.
  • Lipp, P., M. Laine, S. C. Tovey, K. M. Burrell, M. J. Berridge, W. Li, and M. D. Bootman. 2000. Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr. Biol. 10:939–42.
  • Luria, A., S. M. Weldon, A. K. Kabcenell, R. H. Ingraham, D. Matera, H. Jiang, R. Gill, C. Morisseau, J. W. Newman, and B. D. Hammock. 2007. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J. Biol. Chem. 282:2891–98. doi:10.1074/jbc.M608057200.
  • Machado Cda, S., V. P. Venancio, A. F. Aissa, L. C. Hernandes, M. B. de Mello, J. E. Del Lama, C. M. Marzocchi-Machado, M. L. Bianchi, and L. M. Antunes. 2016. Vitamin D3 deficiency increases DNA damage and the oxidative burst of neutrophils in a hypertensive rat model. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 798-799:19–26. doi:10.1016/j.mrgentox.2016.01.005.
  • Mancia, G., R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. Bohm, T. Christiaens, R. Cifkova, G. De Backer, A. Dominiczak, et al. 2013. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34:2159–219. doi:10.1093/eurheartj/eht151.
  • Matyjaszek-Matuszek, B., M. Lenart-Lipinska, and E. Wozniakowska. 2015. Clinical implications of vitamin D deficiency. Prz. Menopauzalny 14:75–81. doi:10.5114/pm.2015.52149.
  • Miller, C. N., and S. Rayalam. 2017. The role of micronutrients in the response to ambient air pollutants: Potential mechanisms and suggestions for research design. J. Toxdicol. Environ. Health B. 20:38–53. doi:10.1080/10937404.2016.1261746.
  • Mitri, J., and A. G. Pittas. 2014. Vitamin D and diabetes, Endocrinology and metabolism clinics of North America . Endocrinol. Metab. Clin. North Am. 43:205–32. doi:10.1016/j.ecl.2013.09.010.
  • Molina-Navarro, M. M., E. Rosello-Lleti, A. Ortega, E. Tarazon, M. Otero, L. Martinez-Dolz, F. Lago, J. R. Gonzalez-Juanatey, F. Espana, P. Garcia-Pavia, et al. 2013. Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. PLoS One 8:e79792. doi:10.1371/journal.pone.0079792.
  • Ni, W., S. W. Watts, M. Ng, S. Chen, D. J. Glenn, and D. G. Gardner. 2014. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension 64:1290–98. doi:10.1161/HYPERTENSIONAHA.114.03971.
  • Norman, A. W. 2001. On becoming a molecular endocrinologist. Steroids 66:129–36.
  • Okamoto, K., and K. Aoki. 1963. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27:282–93.
  • Perez-Hernandez, N., G. Aptilon-Duque, M. C. Nostroza-Hernandez, G. Vargas-Alarcon, J. M. Rodriguez-Perez, and R. Blachman-Braun. 2016. Vitamin D and its effects on cardiovascular diseases: A comprehensive review. Korean J. Intern. Med. 31:1018–29. doi:10.3904/kjim.2015.224.
  • Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29:e45. doi:10.1093/nar/29.9.e45.
  • Pike, J. W., and M. B. Meyer. 2012. The vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum. Dis. Clin. N Am. 38:13–27. doi:10.1016/j.rdc.2012.03.004.
  • Pilz, S., A. Tomaschitz, E. Ritz, and T. R. Pieber. 2009. Vitamin D status and arterial hypertension: A systematic review. Nat Rev Cardiol 6:621–30. doi:10.1038/nrcardio.2009.135.
  • Potter, T. M., B. W. Neun, and S. T. Stern. 2011. Assay to detect lipid peroxidation upon exposure to nanoparticles. Meth. Mol. Biol. 697:181–89.
  • Prosser, D. E., and G. Jones. 2004. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29:664–73. doi:10.1016/j.tibs.2004.10.005.
  • Raed, A., J. Bhagatwala, H. Zhu, N. K. Pollock, S. J. Parikh, Y. Huang, R. Havens, I. Kotak, D.-H. Guo, and Y. Dong. 2017. Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial. PLoS One 12:1–13. doi:10.1371/journal.pone.0188424.
  • Reddy Vanga, S., M. Good, P. A. Howard, and J. L. Vacek. 2010. Role of vitamin D in cardiovascular health. Am. J. Cardiol. 106:798–805. doi:10.1016/j.amjcard.2010.04.042.
  • Reeves, P. G. 1997. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 127 (5 Suppl):838S–841S. doi:10.1093/jn/127.5.838S.
  • Reeves, P. G., F. H. Nielsen, and G. C. Fahey Jr. 1993. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939–51. doi:10.1093/jn/123.11.1939.
  • Rinne, A., and L. A. Blatter. 2010. Activation of NFATc1 is directly mediated by IP3 in adult cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 299:H1701–H1707. doi:10.1152/ajpheart.00470.2010.
  • Ross, A. C. 2011. The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr. 14:938–39. doi:10.1017/S1368980011000565.
  • Sarkar, A., B. K. Saha, R. Basak, I. Mukhopadhyay, R. Karmakar, and M. Chatterjee. 2000. Anticlastogenic potential of 1alpha,25-dihydroxyvitamin D3 in murine lymphoma. Cancer Lett. 150:1–13.
  • Sedlak, J., and R. H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 25:192–205.
  • Sharma, S., G. Ruffenach, S. Umar, N. Motayagheni, S. T. Reddy, and M. Eghbali. 2016. Role of oxidized lipids in pulmonary arterial hypertension. Pulm. Circ. 6:261–73. doi:10.1086/687293.
  • Singh, N. P., M. T. McCoy, R. R. Tice, and E. L. Schneider. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:184–91.
  • Song, J., X. Chen, L. Cheng, M. Rao, K. Chen, N. Zhang, J. Meng, M. Li, Z. Q. Liu, and P. C. Yang. 2018. Vitamin D receptor restricts Th2-biased inflammation in the heart. Cardiovasc. Res. 114:870–79. doi:10.1093/cvr/cvy034.
  • Su, Y. R., and A. G. Menon. 2001. Epithelial sodium channels and hypertension. Drug Metab. Dispos. 29:553–56.
  • Suchkova, I. O., L. I. Pavlinova, E. E. Larionova, N. V. Alenina, K. V. Solov’ev, T. V. Baranova, E. V. Belotserkovskaia, L. K. Sasina, M. Bader, A. D. Denisenko, et al. 2014. [Length polymorphism of minisatellite repeat B2-VNTR of the bradykinin B2 receptor gene in healthy Russians and in patients with coronary heart disease]. Mol. Biol. (Mosk.) 48:752–62.
  • Tallant, E. A., and M. A. Clark. 2003. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1–7). Hypertension 42:574–79. doi:10.1161/01.HYP.0000090322.55782.30.
  • Vieth, R. 1999. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69:842–56. doi:10.1093/ajcn/69.5.842.
  • Wallace, I. R., H. J. Wallace, M. C. McKinley, P. M. Bell, and S. J. Hunter. 2015. Vitamin D and insulin resistance. Clin. Endocrinol. (Oxf) 84:159–71. doi:10.1111/cen.12760.
  • Weng, S., J. E. Sprague, J. Oh, A. E. Riek, K. Chin, M. Garcia, and C. Bernal-Mizrachi. 2013. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 8:e54625. doi:10.1371/journal.pone.0054625.
  • Wong, M. S., R. Delansorne, R. Y. Man, P. Svenningsen, and P. M. Vanhoutte. 2010. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 299:H1226–H1234. doi:10.1152/ajpheart.00288.2010.
  • Yavuzer, H., S. Yavuzer, M. Cengiz, H. Erman, A. Doventas, H. Balci, D. S. Erdincler, and H. Uzun. 2016. Biomarkers of lipid peroxidation related to hypertension in aging. Hypertension Res. 39:342–48. doi:10.1038/hr.2015.156.
  • Yuan, W., W. Pan, J. Kong, W. Zheng, F. L. Szeto, K. E. Wong, R. Cohen, A. Klopot, Z. Zhang, and Y. C. Li. 2007. 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282:29821–30. doi:10.1074/jbc.M705495200.
  • Zhang, Y., G. R. Knutsen, M. D. Brown, and L. B. Ruest. 2013. Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2. Mol. Endocrinol. 27:892–908. doi:10.1210/me.2012-1334.
  • Zhou, Y., Y. Chen, W. P. Dirksen, M. Morris, and M. Periasamy. 2003. AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ. Res. 93:1089–94. doi:10.1161/01.RES.0000101912.01071.FF.
  • Zhou, Y., W. P. Dirksen, Y. Chen, M. Morris, J. L. Zweier, and M. Periasamy. 2005. A major role for AT1b receptor in mouse mesenteric resistance vessels and its distribution in heart and neuroendocrine tissues. J. Mol. Cell. Cardiol. 38:693–96. doi:10.1016/j.yjmcc.2005.02.009.
  • Zimmermann, K., N. Opitz, J. Dedio, C. Renne, W. Muller-Esterl, and S. Oess. 2002. NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 99:17167–72. doi:10.1073/pnas.252345399.
  • Zuk, A., T. Fitzpatrick, and L. C. Rosella. 2016. Effect of vitamin D3 supplementation on inflammatory markers and glycemic measures among overweight or obese adults: A systematic review of randomized controlled trials. PLoS One 11:e0154215. doi:10.1371/journal.pone.0154215.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.